NICOLE DAVIS: Open Payments
NPI 1679932321 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 37 payments from 14 companies in 2025. Trend: 2023 $779 · 2024 $929 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $196 |
| Novo Nordisk Inc | 5 | $89 |
| PFIZER INC. | 4 | $74 |
| Amgen Inc. | 4 | $62 |
| Lilly USA, LLC | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $20 |
Products named: QULIPTA, NURTEC ODT, OTEZLA, Ozempic, MOUNJARO, UBRELVY, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
